je.st
news
Why This Small Victory Against Short Sellers Might Be a Big Deal for Biotech Companies
2015-08-25 18:56:08| Biotech - Topix.net
Acorda Therapeutics, a small New York-based drug maker, just won a round in a rather obscure patent fight with hedge fund manager Kyle Bass. You haven't been following this? The case matters a great deal to the biotech industry, and the implications may stretch far beyond.
Tags: for
small
big
short
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|